Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$6,872,428
+$170,861 QoQ
Shares Held
27,060
-1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.92%
of 13F equity value
Holder Rank
#1,361
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Grey Ledge Advisors, LLC holds $20,654,452 across 8 Drug Manufacturers - General names. JNJ ranks #1 (33.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
27,060 | $6,872,428 | |
| 2 | AMGN |
Amgen Inc
|
13,311 | $4,820,179 | |
| 3 | MRK |
Merck & Co., Inc.
|
32,342 | $4,155,947 | |
| 4 | LLY |
ELI LILLY & Co
|
1,255 | $1,505,284 | |
| 5 | ABBV |
AbbVie Inc.
|
4,550 | $1,144,962 | |
| 6 | NVO |
Novo Nordisk A S
|
21,878 | $1,048,831 | |
| 7 | PFE |
Pfizer Inc
|
29,199 | $703,111 | |
| 8 | NVS |
Novartis AG
|
2,576 | $403,710 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,872,428 | 27,060 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $6,701,567 | 27,416 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $5,721,753 | 27,648 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,462,473 | 29,460 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $4,683,162 | 30,659 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $5,107,042 | 30,795 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $4,422,768 | 30,582 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $5,071,829 | 31,296 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $4,573,346 | 31,290 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $5,038,509 | 31,851 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $5,034,175 | 32,118 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,980,885 | 31,980 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,871,656 | 35,474 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,640,295 | 36,389 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $6,527,040 | 36,949 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $6,951,294 | 42,552 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $7,716,714 | 43,472 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $8,172,252 | 46,111 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $7,940,556 | 46,417 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,976,767 | 18,432 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $7,478,207 | 45,394 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $7,362,551 | 44,798 | Shares | Sole | 2021-08-11 | |
| 2020-12-31 | $629,047 | 3,997 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $832,237 | 5,590 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $786,121 | 5,590 | Shares | Sole | 2020-08-18 | |
| 2020-03-31 | $733,016 | 5,590 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||